No abstract available
MeSH terms
-
Angiogenesis Inhibitors / adverse effects*
-
Angiogenesis Inhibitors / therapeutic use
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Clinical Trials, Phase II as Topic
-
Female
-
Humans
-
Intestinal Perforation / chemically induced*
-
Intestinal Perforation / therapy
-
Neovascularization, Pathologic / drug therapy
-
Ovarian Neoplasms / blood supply
-
Ovarian Neoplasms / drug therapy
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab